Jeffrey W. Sherman, EVP and Chief Medical Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 13,472 shares at $113.05 ($1.5M) on 2023-01-10, disclosed to the SEC on 2023-01-12.
Seasonal sale ($1.5M) by EVP and Chief Medical Officer — this insider has traded HZNP in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.05 | 3,368 | $381K | 25.0% |
| 2 | $113.05 | 3,368 | $381K | 25.0% |
| 3 | $113.10 | 3,368 | $381K | 25.0% |
| 4 | $113.10 | 3,368 | $381K | 25.0% |
| Total | $113.07 avg | 13,472 | $1.5M | 100% |
| Filing → |
| XERS | BUY | 2023-11-29 | $10K | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |
| HZNP | SELL | 2022-12-13 | $6.3M | — | Filing → |